Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Toronto

$641,440.00

Determining the mechanisms through which Rac Isoforms regulate neutrophil chemotaxis

EF 2009-10

Résumé
Background: The microbicidal functions of neutrophils (PMN) are highly dependent on their ability to migrate from the vasculature into infected sites. This directed migration, or chemotaxis, involves two key steps: 1) compass-like sensing of the chemoattractant gradient; and 2) actin assembly in the leading lamella mediated through the actin binding protein cofilin, which drives cell migration towards the chemoattractant. Rho family small GTPases including Rac, Rho and Cdc42, are important regulators of cell migration that impact health and disease. For example, patients with a Rac2 mutation exhibit a severe PMN chemotactic defect and experience life threatening bacterial infections. Severe PMN chemotactic defects typify Rac1 and Rac2 null mice, experimental models which we developed to study Rac isoform function in PMNs. Goal: Define how these highly homologous Rac proteins carry out their unique signaling roles during PMN chemotaxis and recruitment to sites of infection. Significance: The transgenic mouse models and the combination of novel techniques used in this grant will permit biochemical and functional examination of the local signaling roles played by Rac1 and Rac2 and their downstream ROS activated signaling elements in actin-mediated PMN chemotaxis. Over the long-term, this knowledge will allow us to identify key downstream mediators of PMN recruitment to sites of infection and inflammation. By better understanding the signaling elements involved in the key aspects of PMN chemotaxis we will be able to translate this information into more specific and promising anti-inflammatory drugs.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
200005
Name
Glogauer Michael
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
Determining the mechanisms through which Rac Isoforms regulate neutrophil chemotaxis
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$641,440
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Chemotaxis; Innate Immunity; Neutrophils; Rac; Rho Small Gtpases
Abstract
Background: The microbicidal functions of neutrophils (PMN) are highly dependent on their ability to migrate from the vasculature into infected sites. This directed migration, or chemotaxis, involves two key steps: 1) compass-like sensing of the chemoattractant gradient; and 2) actin assembly in the leading lamella mediated through the actin binding protein cofilin, which drives cell migration towards the chemoattractant. Rho family small GTPases including Rac, Rho and Cdc42, are important regulators of cell migration that impact health and disease. For example, patients with a Rac2 mutation exhibit a severe PMN chemotactic defect and experience life threatening bacterial infections. Severe PMN chemotactic defects typify Rac1 and Rac2 null mice, experimental models which we developed to study Rac isoform function in PMNs. Goal: Define how these highly homologous Rac proteins carry out their unique signaling roles during PMN chemotaxis and recruitment to sites of infection. Significance: The transgenic mouse models and the combination of novel techniques used in this grant will permit biochemical and functional examination of the local signaling roles played by Rac1 and Rac2 and their downstream ROS activated signaling elements in actin-mediated PMN chemotaxis. Over the long-term, this knowledge will allow us to identify key downstream mediators of PMN recruitment to sites of infection and inflammation. By better understanding the signaling elements involved in the key aspects of PMN chemotaxis we will be able to translate this information into more specific and promising anti-inflammatory drugs.
Competitiondate
201003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Glogauer, Michael
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $641,440~ $0~